Cargando…

Novel Drugs Development for Cardio-/Cerebrovascular Diseases

Detalles Bibliográficos
Autores principales:	Sheu, Joen-Rong, Thomas, Philip Aloysius, Cheng, Juei-Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087293/ https://www.ncbi.nlm.nih.gov/pubmed/25045682 http://dx.doi.org/10.1155/2014/467936

Ejemplares similares

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases
por: Sheu, Joen-Rong, et al.
Publicado: (2014)

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases 2015
por: Sheu, Joen-Rong, et al.
Publicado: (2015)

Innovative Targeting Strategies in Drug Therapy for Inflammatory Diseases: Mechanistic Approaches
por: Chou, Duen-Suey, et al.
Publicado: (2015)

The Impact of Aging on Cardio and Cerebrovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2018)

New Insights into Antithrombotic Therapy for Cardio- and Cerebrovascular Disease: From Molecular Mechanisms to Clinical Application
por: Cirillo, Plinio, et al.
Publicado: (2023)

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
por: Su, Jian-Hui, et al.
Publicado: (2021)

Molecular Pharmacology and Pathology of Strokes
por: Sheu, Joen-Rong
Publicado: (2018)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2016)

Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
por: Bai, Xue, et al.
Publicado: (2020)

Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
por: Luo, Meng-Yi, et al.
Publicado: (2021)

Multi-Targeting Andrographolide, a Novel NF-κB Inhibitor, as a Potential Therapeutic Agent for Stroke
por: Yang, Chih-Hao, et al.
Publicado: (2017)

The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases
por: Li, Jing, et al.
Publicado: (2023)

Dietary patterns and cardio-cerebrovascular disease in a Chinese population
por: Wang, Honglin, et al.
Publicado: (2015)

Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.
por: Li, Dan, et al.
Publicado: (2022)

The Transfer Patterns of Vulnerable Populations with Acute Cardio-Cerebrovascular Diseases
por: Choi, E H, et al.
Publicado: (2023)

Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges
por: Huajuan, Jiang, et al.
Publicado: (2023)

Storax, A Promising Botanical Medicine for Treating Cardio-Cerebrovascular Diseases: A Review
por: Xu, Zhuo, et al.
Publicado: (2021)

Rheumatoid Arthritis and Cardio-Cerebrovascular Disease: A Mendelian Randomization Study
por: Qiu, Shizheng, et al.
Publicado: (2021)

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Genetic Predispositions Between COVID-19 and Three Cardio-Cerebrovascular Diseases
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
por: Signori, Davide, et al.
Publicado: (2022)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review
por: Zhang, Zixi, et al.
Publicado: (2023)

Cardio-oncology: need for novel structures
por: Michel, Lars, et al.
Publicado: (2019)

Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease
por: Badimon, Juan J., et al.
Publicado: (2022)

Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease
por: Wang, Zi-Ying, et al.
Publicado: (2015)

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
por: Lv, Jun-Xuan, et al.
Publicado: (2017)

Association between gallstone and cardio-cerebrovascular disease: Systematic review and meta-analysis
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review
por: Zhang, Kexin, et al.
Publicado: (2023)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

Relationship between Parkinson’s disease and cardio-cerebrovascular diseases: a Mendelian randomized study
por: Zhou, Zhongzheng, et al.
Publicado: (2023)

Artificial Intelligence: A Shifting Paradigm in Cardio-Cerebrovascular Medicine
por: Abedi, Vida, et al.
Publicado: (2021)

Astaxanthin, a Carotenoid, Stimulates Immune Responses by Enhancing IFN-γ and IL-2 Secretion in Primary Cultured Lymphocytes in Vitro and ex Vivo
por: Lin, Kuan-Hung, et al.
Publicado: (2015)

Increased risk of cardio-cerebrovascular disease after hematopoietic cell transplantation in patients with previous history
por: Peng, Bo, et al.
Publicado: (2021)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

Molecular Mechanisms of Cerebrovascular Diseases
por: Andjelkovic, Anuska V., et al.
Publicado: (2022)

Blood Pressure Awareness and Knowledge of Cardio-Cerebrovascular Diseases in South Korean Women with Hypertension
por: Jeong, Yeo Won
Publicado: (2021)

The role of carbonic anhydrase III and autophagy in type 2 diabetes with cardio-cerebrovascular disease
por: Zhang, Xiao-Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cblo8vqghv1qj4unv0rt7jena6